FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2300151504> ?p ?o ?g. }

• W2300151504 endingPage "2199" @default.
• W2300151504 startingPage "2193" @default.
• W2300151504 abstract "There have been few studies in which the prevalence of cerebral atrophy in childhood-onset systemic lupus erythematosus (SLE) was evaluated using magnetic resonance imaging (MRI) volumetric measurements. This study was undertaken to determine the prevalence of cerebral and corpus callosum atrophy in childhood-onset SLE and to determine the possible relationships between atrophy and clinical, laboratory, and treatment features of the disease.We included 76 patients with childhood-onset SLE (69 female and 7 male; median age 16 years) and 66 age- and sex-matched healthy controls. Neurologic manifestations were analyzed according to the American College of Rheumatology (ACR) criteria. These SLE patients were further assessed for clinical and laboratory manifestations of SLE, disease activity (using the SLE Disease Activity Index), damage (using the Systemic Lupus International Collaborating Clinics/ACR Damage Index), and current and cumulative drug exposures. Scans were performed with a Philips 3.0T MRI scanner using a standardized protocol.Childhood-onset SLE patients had significantly smaller cerebral and corpus callosum volumes than controls (median cerebral volume 1,067.9 cm(3) versus 1,172.7 cm(3) and median corpus callosum volume 11.6 cm(3) versus 13.7 cm(3) ; P < 0.001). The presence of structural abnormalities was observed in 42 patients (55.3%) with childhood-onset SLE. The presence of cerebral atrophy was associated with anticardiolipin antibodies (aCL) (P = 0.02), anti-double-stranded DNA (P = 0.02), and cumulative corticosteroid dose (P = 0.04). The presence of corpus callosum atrophy was associated with low complement level (P = 0.006) and acute confusional state (P = 0.01). Serum levels of S100B or high molecular weight neurofilament and the presence of anti-ribosomal P were not associated with atrophy.Structural brain abnormalities were observed in 55.3% of the patients and were associated with neuropsychiatric manifestations, aCL, and corticosteroid use. To determine permanent neurologic damage, longitudinal studies must be conducted in these patients." @default.
• W2300151504 created "2016-06-24" @default.
• W2300151504 creator A5017313946 @default.
• W2300151504 creator A5017698959 @default.
• W2300151504 creator A5018854495 @default.
• W2300151504 creator A5037728652 @default.
• W2300151504 creator A5044809264 @default.
• W2300151504 creator A5055865638 @default.
• W2300151504 creator A5061052463 @default.
• W2300151504 creator A5077104703 @default.
• W2300151504 creator A5088481433 @default.
• W2300151504 creator A5089813520 @default.
• W2300151504 date "2016-08-25" @default.
• W2300151504 modified "2023-10-18" @default.
• W2300151504 title "Reduction of Cerebral and Corpus Callosum Volumes in Childhood-Onset Systemic Lupus Erythematosus: A Volumetric Magnetic Resonance Imaging Analysis" @default.
• W2300151504 cites W1483826902 @default.
• W2300151504 cites W1489292616 @default.
• W2300151504 cites W1532755881 @default.
• W2300151504 cites W1963831622 @default.
• W2300151504 cites W1969642784 @default.
• W2300151504 cites W1973230007 @default.
• W2300151504 cites W1974572404 @default.
• W2300151504 cites W1976588148 @default.
• W2300151504 cites W1978279359 @default.
• W2300151504 cites W1979776035 @default.
• W2300151504 cites W1980674214 @default.
• W2300151504 cites W2018455360 @default.
• W2300151504 cites W2022070992 @default.
• W2300151504 cites W2027706393 @default.
• W2300151504 cites W2028262213 @default.
• W2300151504 cites W2038511894 @default.
• W2300151504 cites W2056101593 @default.
• W2300151504 cites W2062016899 @default.
• W2300151504 cites W2064921702 @default.
• W2300151504 cites W2064999867 @default.
• W2300151504 cites W2067495470 @default.
• W2300151504 cites W2068475898 @default.
• W2300151504 cites W2070527591 @default.
• W2300151504 cites W2073222837 @default.
• W2300151504 cites W2078359840 @default.
• W2300151504 cites W2085105520 @default.
• W2300151504 cites W2085279645 @default.
• W2300151504 cites W2086851436 @default.
• W2300151504 cites W2087211547 @default.
• W2300151504 cites W2120073503 @default.
• W2300151504 cites W2122062577 @default.
• W2300151504 cites W2126681984 @default.
• W2300151504 cites W2146203649 @default.
• W2300151504 cites W2154480805 @default.
• W2300151504 cites W2156641031 @default.
• W2300151504 cites W2165801371 @default.
• W2300151504 cites W2331930580 @default.
• W2300151504 cites W2561536790 @default.
• W2300151504 cites W4238079920 @default.
• W2300151504 cites W4296981399 @default.
• W2300151504 doi "https://doi.org/10.1002/art.39680" @default.
• W2300151504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26991912" @default.
• W2300151504 hasPublicationYear "2016" @default.
• W2300151504 type Work @default.
• W2300151504 sameAs 2300151504 @default.
• W2300151504 citedByCount "16" @default.
• W2300151504 countsByYear W23001515042017 @default.
• W2300151504 countsByYear W23001515042018 @default.
• W2300151504 countsByYear W23001515042021 @default.
• W2300151504 countsByYear W23001515042022 @default.
• W2300151504 countsByYear W23001515042023 @default.
• W2300151504 crossrefType "journal-article" @default.
• W2300151504 hasAuthorship W2300151504A5017313946 @default.
• W2300151504 hasAuthorship W2300151504A5017698959 @default.
• W2300151504 hasAuthorship W2300151504A5018854495 @default.
• W2300151504 hasAuthorship W2300151504A5037728652 @default.
• W2300151504 hasAuthorship W2300151504A5044809264 @default.
• W2300151504 hasAuthorship W2300151504A5055865638 @default.
• W2300151504 hasAuthorship W2300151504A5061052463 @default.
• W2300151504 hasAuthorship W2300151504A5077104703 @default.
• W2300151504 hasAuthorship W2300151504A5088481433 @default.
• W2300151504 hasAuthorship W2300151504A5089813520 @default.
• W2300151504 hasConcept C126322002 @default.
• W2300151504 hasConcept C126838900 @default.
• W2300151504 hasConcept C142724271 @default.
• W2300151504 hasConcept C143409427 @default.
• W2300151504 hasConcept C164705383 @default.
• W2300151504 hasConcept C2778183499 @default.
• W2300151504 hasConcept C2779717322 @default.
• W2300151504 hasConcept C2781172350 @default.
• W2300151504 hasConcept C71924100 @default.
• W2300151504 hasConceptScore W2300151504C126322002 @default.
• W2300151504 hasConceptScore W2300151504C126838900 @default.
• W2300151504 hasConceptScore W2300151504C142724271 @default.
• W2300151504 hasConceptScore W2300151504C143409427 @default.
• W2300151504 hasConceptScore W2300151504C164705383 @default.
• W2300151504 hasConceptScore W2300151504C2778183499 @default.
• W2300151504 hasConceptScore W2300151504C2779717322 @default.
• W2300151504 hasConceptScore W2300151504C2781172350 @default.
• W2300151504 hasConceptScore W2300151504C71924100 @default.
• W2300151504 hasFunder F4320320997 @default.
• W2300151504 hasFunder F4320322025 @default.
• W2300151504 hasIssue "9" @default.

• next